Tags: acute myeloid leukemiaAMLatra-iceatraicebloodblood cancerblood marrowblood samplecancercancer prognosischemotherapyconsolidationcumulative incidencecumulative incidence of relapsegenetic mutationgetuzumabgetuzumab ozogamicinhematologyinductionleukemiamutationnpm1npm1mutnucleophosmin1 mutated acute myeloid leukemiaoncologyprognostic factorprognostic testrelapse rateresidual diseaseresidual disease negativitytreatment cycles
Want more physician-written
medical news?
Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.
Subscribe for free today!